These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 9554360)

  • 1. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral needle ablation of the prostate: report of initial United States clinical trial.
    Issa MM
    J Urol; 1996 Aug; 156(2 Pt 1):413-9. PubMed ID: 8683692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
    Kahn SA; Alphonse P; Tewari A; Narayan P
    J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup.
    Gilling PJ; Mackey M; Cresswell M; Kennett K; Kabalin JN; Fraundorfer MR
    J Urol; 1999 Nov; 162(5):1640-4. PubMed ID: 10524887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia.
    Narayan P; Tewari A; Aboseif S; Evans C
    J Urol; 1995 Dec; 154(6):2083-8. PubMed ID: 7500464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: the Emory University Experience.
    Issa MM; Perez-Brayfield M; Petros JA; Anastasia K; Labadia AJ; Miller LE
    J Urol; 1999 Nov; 162(5):1636-9. PubMed ID: 10524886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.
    Arai Y; Aoki Y; Okubo K; Maeda H; Terada N; Matsuta Y; Maekawa S; Ogura K
    J Urol; 2000 Oct; 164(4):1206-11. PubMed ID: 10992367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
    Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
    J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of safety and efficacy of transurethral resection of the prostate using contact laser versus electrocautery.
    Zorn BH; Bauer JJ; Ruiz HE; Thrasher JB
    Tech Urol; 1999 Dec; 5(4):198-201. PubMed ID: 10591258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
    van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
    J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup.
    Hon NH; Brathwaite D; Hussain Z; Ghiblawi S; Brace H; Hayne D; Coppinger SW
    J Urol; 2006 Jul; 176(1):205-9. PubMed ID: 16753403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Office based transurethral needle ablation of the prostate with analgesia and local anesthesia.
    Leocádio DE; Frenkl TL; Stein BS
    J Urol; 2007 Nov; 178(5):2052-4; discussion 2054. PubMed ID: 17869294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study.
    Flanigan RC; Reda DJ; Wasson JH; Anderson RJ; Abdellatif M; Bruskewitz RC
    J Urol; 1998 Jul; 160(1):12-6; discussion 16-7. PubMed ID: 9628595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.